Skip to main content
Ready to start planning your care? Call us at 833-347-1665 to make an appointment.
-
Development of high-resolution ultra-deep pan-proteomic profiling of primary human tumors by mass spectrometry
-
Integrated proteogenomic “big data” analyses of tumors using WGS/WES, RNA-Seq, and LC-MS datasets
-
Characterization of phosphoproteomic tumor signaling adaptation under targeted therapies (response vs. resistance)
-
Highly multiplexed quantitative protein biomarker assessment in clinical trials using LC-MS/MS
-
Elucidating the “antigen-ome” of autoreactive immunogenic tumor neoantigens in solid tumors